Longitudinal change of serum inter‐alpha‐trypsin inhibitor heavy chain H4, and its correlation with inflammation, multiorgan injury, and death risk in sepsis
Journal of Clinical Laboratory Analysis · 2023
DOI: 10.1002/jcla.24834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2023. Verfasst von Xiangwang Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Shanghai East Hospital, Shanghai, China. Hauptthemen laut MEDLINE: Sepsis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Background
Inter‐alpha‐trypsin inhibitor heavy chain H4 (ITIH4) inhibits infection‐induced inflammation and multiorgan injury through several methods. The present study aimed to estimate the association of serum ITIH4 with inflammatory cytokines, multiorgan injury, and death risk in sepsis patients.
Methods
Serum samples were collected to detect ITIH4 by enzyme‐linked immunosorbent assay in 127 sepsis patients at admission (baseline), day (D)1, D3, and D7 after admission, as well as in 30 healthy controls (HCs). Additionally, 28‐day mortality was recorded in sepsis patients.
Results
ITIH4 was reduced in sepsis patients versus HCs (median [interquartile range]: 147.9 [78.2–208.8] vs. 318.8 [237.2–511.4] ng/ml) ( p < 0.001). In sepsis patients, ITIH4 was associated with the absence of cardiovascular and cerebrovascular disease history ( p = 0.021). Additionally, ITIH4 was negatively correlated with tumor necrosis factor‐α ( p < 0.001), interleukin (IL)‐1β ( p < 0.001), IL‐6 ( p = 0.019), IL‐17A ( p = 0.002), and C‐reactive protein ( p = 0.001), but positively related to IL‐10 ( p = 0.007). Moreover, ITIH4 was also inversely associated with Acute Physiology and Chronic Health Evaluation II score ( p = 0.002), Sequential Organ Failure Assessment (SOFA) score ( p < 0.001), SOFA‐respiratory system score ( p = 0.023), and SOFA‐renal system score ( p = 0.007). Interestingly, ITIH4 gradually increased from baseline to D7 ( p < 0.001); besides, ITIH4 at baseline ( p = 0.009), D1 ( p = 0.002), D3 ( p < 0.001), and D7 ( p = 0.015) were all decreased in sepsis deaths versus sepsis survivors.
Conclusion
Serum ITIH4 is raised from baseline to D7 after disease onset, and it reflects the reduction of systemic inflammation, disease severity, and 28‐day mortality for sepsis. However, further verification is required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, Shanghai East Hospital, Shanghai, China.
- Department of Intensive Care Medicine, The Third People's Hospital, Qingdao, China.
ORCID-Profile: Yusheng Li
Zitieren
APA
Zhao, X., Guo, Y., Li, L., & Li, Y. (2023). Longitudinal change of serum inter‐alpha‐trypsin inhibitor heavy chain H4, and its correlation with inflammation, multiorgan injury, and death risk in sepsis. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.24834
Vancouver
Zhao X, Guo Y, Li L, Li Y. Longitudinal change of serum inter‐alpha‐trypsin inhibitor heavy chain H4, and its correlation with inflammation, multiorgan injury, and death risk in sepsis. Journal of Clinical Laboratory Analysis. 2023. doi:10.1002/jcla.24834
BibTeX
@article{Zhao2023,
author = {Zhao, Xiangwang and Guo, Yong and Li, Lingyu and Li, Yusheng},
title = {Longitudinal change of serum inter‐alpha‐trypsin inhibitor heavy chain H4, and its correlation with inflammation, multiorgan injury, and death risk in sepsis},
journal = {Journal of Clinical Laboratory Analysis},
year = {2023},
doi = {10.1002/jcla.24834}
}
EUVIMED